| Type | AASa (N = 539) | Others Substancesb (N = 125) | df | χ 2 | Sig |
|---|
| N (%) | N (%) |
|---|
| Gender |
| Male | 489 (90.7) | 115 (92) | 1 | .201 | .065 |
| Female | 50 (9.3) | 10 (8.0) | | | |
| Year |
| 2012 | 22 (4.1) | 7 (5.6) | 5 | 19.701 | .001 |
| 2013 | 59 (11,0) | 23 (18.4) | | | |
| 2014 | 158 (29.3) | 24 (19.2) | | | |
| 2015 | 87 (16.1) | 21 (16.8) | | | |
| 2016 | 112 (20.8) | 39 (31.2) | | | |
| 2017 | 101 (18.7) | 11 (8.8) | | | |
| Place of Seizure |
| Land and Air ports of entry | 118 (21.9) | 10 (8.0) | 3 | 13.594 | .004 |
| Mail and Packages processing centers | 207 (38.4) | 51 (40.8) | | | |
| Private premises | 181 (33.6) | 55 (44.0) | | | |
| Public or commercial properties | 33 (6.1) | 9 (7.2) | | | |
- aAnabolic Androgenic Steroids
- bWADA prohibited substances from the following categories: Adrenergic and sympathomimetic agent; Diuretics, Sodium and potassium supplements; Hormones, Growth hormones, and hormone releasing agent; Post-cycle and adverse effects treatment agents and site-enhancing oils
